February 10, 2026

Vator Securities advises BiBBInstruments on SEK 60 million Capital Raise

About BiBBInstruments AB 

BiBBInstruments AB is a cancer diagnostics company that develops and manufactures EndoDrill®, a patented product line of electric-driven endoscopic biopsy instruments. EndoDrill® enables tissue sampling with high precision and quality, with the aim of improving the diagnosis of several serious cancers, including those of the stomach, pancreas, liver, lungs, and bladder. BiBB's product portfolio targets the global market for ultrasound-guided endoscopic (EUS/EBUS) biopsy instruments - the most advanced and fastest-growing segment of endoscopy.  

In 2023, BiBB's lead product EndoDrill® GI received 510(k) clearance from the U.S. FDA. In early 2024, CE marking was obtained under the new MDR regulatory framework for all three product variants: EndoDrill® GI, EndoDrill® EBUS, and EndoDrill® URO. As a result, EndoDrill® became the first market-cleared electric-driven endoscopic biopsy system in both the U.S. and Europe. 

The US launch of EndoDrill® GI began in the fall of 2025 in collaboration with TaeWoong Medical USA. EndoDrill® consists of sterile, single-use instruments paired with a dedicated drive system. BiBB was founded in 2013 by Dr. Charles Walther - cancer researcher at Lund University and senior consultant in clinical pathology at Skåne University Hospital 

The net proceeds from the Share Issue: 

  • are primarily intended to be used to accelerate the commercial launch in the US and initiate the launch in Europe, strengthen distributor support, and finance the next major product expansion, EndoDrill® EBUS for lung cancer, including FDA 510(k) approval, clinical pilot studies, and launch start. 
  • will also support key clinical programs, including the planned multicenter study for EndoDrill® GI, and drive cost optimization initiatives, such as improved purchasing, volume-based reductions in material costs, and implementation of internal systems necessary to streamline administrative processes and enable scalable and efficient commercial expansion. 


Press release 

Website: https://bibbinstruments.com/en/